Information from the abstract
Despite strong evidence supporting the benefits of sodium-glucose cotransporter-2 inhibitor (SGLT2i) for managing type 2 diabetes, heterogeneity of treatment response is rarely assessed. This study aims to demonstrate the heterogeneity effects of SGLT2i for preventing chronic kidney disease (CKD) via a causal machine learning model. A retrospective cohort study was conducted. Data from 2,280 type 2 diabetes patients were used to develop a double/debiased machine learning (DDML) model for CKD prediction; a conventional treatment effect (TE) model was also constructed for comparison. Model performance was evaluated using area under the receiver operating characteristic curve, and calibration plot. Subsequently, average treatment effects (ATEs) and conditional average treatment effects (CATEs) of SGLT2i versus non-SGLT2i were estimated and compared among models. A neural network (NN) was selected for the DDML framework for CKD prediction. Although the conventional TE model demonstrated slightly better discrimination and calibration, the DDML-NN produced comparable results. The ATEs (95% confidence interval) estimated by DDML-NN and conventional TE models were –0.0399 (–0.0600, –0.0199) and − 0.0424 (− 0.0616, − 0.0232), respectively. Corresponding CATE ranges were –0.3945 to 0.2495 and − 0.6968 to 0.0026. Patients gaining higher benefits from SGLT2i trended to be older, male, and overweight, compared to who were benefited less from SGLT2i. The protective effect of SGLT2i against CKD was indicated, albeit heterogeneous. Counterfactual models including DDML-NN and conventional TE models demonstrated similar performance. However, data from a larger cohort are still required to draw a firm conclusion.
Why this record is monitored
This record has an Impact Signal of 79/100 based on recency, source, collaboration, and bibliographic signals. It prioritizes monitoring and is not a judgment of research quality.
Related topics: Diabetes Treatment and Management · Chronic Kidney Disease and Diabetes · Bariatric Surgery and Outcomes
Thai researcher and institutional participation
Tanawan Kongmalai · Panu Looareesuwan · Amarit Tansawet · Sukanya Siriyotha · Patratorn Kunakorntham · Burin Boonwatcharapai · Ammarin Thakkinstian · Siriraj Hospital · Mahidol University · Ramathibodi Hospital · Chulalongkorn University · King Chulalongkorn Memorial Hospital
Data limitations
This page is a bibliographic record based on abstract-level information, not a full analysis or quality assessment. Verify the DOI and original article before citation.